NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended September 30, 2025 after the close of the market on Thursday, November 6, 2025. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States ma ...

Financial Data and Key Metrics Changes - Second quarter revenue grew 9.5% year-over-year to $332.9 million, primarily due to an increase in the number of clients and covered lives [20] - Adjusted EBITDA grew 6% to $58 million, with an adjusted EBITDA margin of 17.4%, a slight decline from the previous year [28] - Net income was $17.1 million, or $0.19 per diluted share, compared to $16.5 million, or $0.17 per diluted share in the prior year [28] Business Line Data and Key Metrics Changes - Fertility benefits revenue increased 11% year-over-year to $214 million, while pharmacy revenue increased 8% to $119 million [26] - Nearly 17,000 ART cycles were performed in the quarter, a 9% increase over the second quarter last year [26] - Female utilization was 0.48%, slightly above the second quarter of the previous year [25] Market Data and Key Metrics Changes - As of June 30, the company had 542 clients with at least 1,000 lives, representing an average of 6.74 million covered lives, compared to 463 clients and 6.41 million covered lives a year ago [21] - The company expects to approach 6.8 million covered lives following additional client launches [22] - The diversity of clients across various industries provides insulation from sector-specific activities [24] Company Strategy and Development Direction - The company aims to expand market share through new client acquisition, maintain high client retention, and attract partners to enhance distribution reach [6][7] - Recent acquisitions, such as Benefit Bump, have been integrated to enhance service offerings [12] - The company is focused on expanding its product portfolio and enhancing member experience through technology and partnerships [18] Management's Comments on Operating Environment and Future Outlook - Management noted healthy member engagement levels consistent with historical patterns and raised full-year guidance due to strong first-half results [5][34] - The company anticipates continued growth in ART cycles and has modestly increased full-year utilization assumptions [32] - Management expressed confidence in achieving revenue growth of 5.8% to 8.8% for the full year, excluding the impact of a large former client [34] Other Important Information - The company generated $55.5 million in operating cash flow in the second quarter, highlighting strong cash flow conversion [29] - The company has no debt and entered into a revolving credit facility for additional liquidity [30] - The integration of new services, such as pelvic floor therapy, is expected to enhance overall women's health offerings [15] Q&A Session Summary Question: Is the commentary around the selling season and early commitments on a gross basis? - Management confirmed it is on a gross basis, excluding the large client contribution from both years [36] Question: Are smaller clients signing up for multiple services while larger clients take longer to decide? - Management clarified that the sales year started slower but caught up in June and July, with large clients also closing deals [40][41] Question: Is there a difference in expected revenue based on the demographics of new clients? - Management indicated that the demographics yield a higher expected revenue based on the industries of new clients [60][71] Question: How is the growth of Progyny Rx compared to fertility benefits? - Management stated that growth in Progyny Rx is more about timing and expects it to be close to medical by the end of the year [44] Question: Can you provide insights on the mix of services and pricing? - Management noted that there was nothing significant to call out regarding the mix this quarter compared to prior periods [76] Question: Has the company ever had clients that left and then returned? - Management confirmed that there have been instances of clients returning, although no specific names were mentioned [81]